학술논문

Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials
Document Type
Article
Source
In: JACC: CardioOncology. (JACC: CardioOncology, April 2024, 6(2):267-279)
Subject
Language
English
ISSN
26660873